A first in Patient study of CLF-065
Latest Information Update: 26 Jun 2023
At a glance
- Drugs CLF-065 (Primary)
- Indications Inflammatory bowel diseases
- Focus Adverse reactions
Most Recent Events
- 26 Jun 2023 New trial record
Latest Information Update: 26 Jun 2023